id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
anesthj-152	Nicholson, Samantha	Hypotension and Bradycardia with Sugammadex Administration	2021	2	.pdf	application/pdf	190	5	19	Samantha Nicholson is a Registered Nurse pursuing her DNP in Nurse Anesthesia at Texas Christian University KEYWORDS: sugammadex, Bridion®, reversal agent, adverse drug reaction Abstract The Food and Drug Administration (FDA) approved sugammadex for use as a reversal agent for nondepolarizing muscle relaxants.1 Sugammadex binds free molecules of muscle relaxant, specifically rocuronium and vecuronium, resulting in a rapid offset of neuromuscular blockade.2 When compared to the use of neostigmine and glycopyrrolate for reversal, sugammadex has shown to be faster and able to provide reversal for deeper blockades.2 However, this new drug is not without risks. No. 5 2021 Educated Hand Publishing LLC “The Science Behind the Art” Volume 9 - No.5 2021 Anesthesia eJournal - Online ISSN 2333-2611 Page 9 Hypotension and Bradycardia with Sugammadex Administration Samantha Nicholson, BSN, RN, CCRN Affiliation: Texas Christian University Grant/Financial Support: None Biographical data:	cache/anesthj-152.pdf	txt/anesthj-152.txt